Tulane Home Tulane Home
Subscribe to NIH Grants feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 17 hours 2 min ago

Request for Information on Existing Data Sharing Processes for NIH-Funded Research

Thu, 02/02/2023 - 08:08
Notice NOT-CA-23-023 from the NIH Guide for Grants and Contracts

NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)

Wed, 02/01/2023 - 09:30
Funding Opportunity PAR-23-111 from the NIH Guide for Grants and Contracts. NIMHD invites applications to support short-term exploratory or developmental research projects that have the potential to break new ground in the fields of minority health and/or health disparities or extend previous discoveries toward new directions or applications that can directly contribute to improving minority health and/or reducing health disparities in the U.S.

Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)

Wed, 02/01/2023 - 08:25
Funding Opportunity RFA-EB-23-001 from the NIH Guide for Grants and Contracts. Ethical considerations are intrinsic to the conduct of robotic and bionic device research. This Funding Opportunity Announcement (FOA) invites applications that propose research on ethical questions associated with all stages of the design, testing, and/or implementation of bionic and robotic devices.

Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)

Tue, 01/31/2023 - 02:07
Funding Opportunity PAR-23-089 from the NIH Guide for Grants and Contracts. This FOA invites applications from multidisciplinary teams to perform secondary data analysis, using existing datasets from two or more multi-site clinical research projects, to address scientific and clinical hypotheses relevant to neurological disorders and conditions within the NINDS mission. In this phased funding mechanism, applications are required to systematically and comprehensively perform cross-project data harmonization and curation, assessed using Go/No-go data-quality metrics, prior to funding of the second phase of data analyses. Consistent with the FAIR (findable, accessible, interoperable and reusable) data principles, this funding opportunity expects open-source cataloging of the processes and tools used for harmonization, curation, and analysis, as well as controlled access to the curated datasets.

Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)

Tue, 01/31/2023 - 02:01
Funding Opportunity RFA-AG-24-018 from the NIH Guide for Grants and Contracts. This FOA invites applications proposing to establish new, or significantly expand existing, interdisciplinary collaborations involving both experimental and computational researchers to simultaneously address a targeted research question in brain aging and Alzheimer's disease (AD),including Alzheimer's disease related dementias (ADRD). This FOA will use the R21/R33 to provide up to 2 years of R21 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable interdisciplinary collaboration across experimental and computational laboratories to support projects that address key research questions in brain aging and AD/ADRD.

Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)

Tue, 01/31/2023 - 00:31
Funding Opportunity PAR-22-262 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients.

Request for Information (RFI): Input for developing the 2024-2028 National Institute of Environmental Health Sciences Strategic Plan

Tue, 01/31/2023 - 00:23
Notice NOT-ES-23-005 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI) for Administrative Supplements: Harmonization and Joint Analysis of Human Brain Single-Cell Datasets

Mon, 01/30/2023 - 11:21
Notice NOT-NS-23-042 from the NIH Guide for Grants and Contracts

Notice to expire NIHs Continuity Supplements (NOT-OD-20-054 and NOT-OD-20-055)

Mon, 01/30/2023 - 09:18
Notice NOT-OD-23-074 from the NIH Guide for Grants and Contracts

Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)

Mon, 01/30/2023 - 09:05
Funding Opportunity RFA-MD-23-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined population groups who experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.

Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)

Mon, 01/30/2023 - 08:58
Funding Opportunity RFA-MD-23-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations experiencing health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.

Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)

Mon, 01/30/2023 - 08:41
Funding Opportunity PAR-23-112 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support intervention research that addresses structural racism and discrimination (SRD) to improve minority health or reduce health disparities.

Pages